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Abstract
Purpose Not long after the introduction of osseointegrated implants outside the oral cavity, auricular prostheses are retrained 
on osseointegrated implants. New insights have been gained with the next-generation percutaneous osseointegrated titanium 
implants for bone conduction hearing since its introduction in 2010. As a result, the same technology was introduced in the 
 Vistafix® system (VXI implant) to retain auricular prostheses. The aim of this study is to evaluate the surgical procedure, 
clinical outcome, and satisfaction of the patient of osseointegration-retained auricular prosthesis using VXI implants.
Materials and methods 11 patients who received an auricular prosthesis using VXI implants between December 2012 and 
November 2017 were evaluated retrospectively. The patient’s medical files were reviewed to assess clinical complications 
and the necessity for revision surgery. The subjective outcome was measured using the Glasgow benefit inventory (GBI).
Results In total, 31 implants were placed in 11 patients. None of these implants were lost nor revision surgery needed. An 
adverse skin reaction was observed in 13.0% of the implants and in 27.2% of the patients, adequately treated with an anti-
biotic ointment. The average follow-up time was 2 years and 7 months. The GBI displayed a positive score in every patient.
Conclusions The VXI implants used are a safe and reliable treatment option for retaining auricular prostheses in patients 
with an absent auricle. Patients were satisfied with their auricular prosthesis and showed benefit in quality of life. Studies 
with larger numbers and preferably a prospective character are needed to draw statistically significant conclusions.
Keywords Implants · Auricle · Prosthesis · Microtia · Skin reactions · Hearing loss
Abbreviations
VXI implants  Vistafix® implants
VXA abutments  Vistafix® abutments
CT  Computed tomography
BCD  Bone conduction device
GBI  Glasgow benefit inventory
Introduction
Different causes of an absent auricle exist and can mainly 
be divided into congenital and acquired. Congenitally, the 
(partially) absent auricle, i.e. microtia can arise as a result 
of a single, unique genetic feature or as a part of a syndrome 
and can be classified into several types with or without atre-
sia of the external auditory meatus [1, 2]. Acquired forms 
of an absent auricle arise from traumatic events, dissatisfy-
ing reconstruction or after amputation as a result of surgical 
treatment of advanced cancer of the auricle and/or external 
auditory meatus [3, 4].
Since complete care of the auricle is advocated, hearing 
revalidation requires attention in patients with a congeni-
tal absent auricle. It has been demonstrated that unilateral 
hearing loss in children might be associated with delayed 
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speech-language development and behavioural problems 
occur more frequently [5, 6]. Thereby, different treatment 
options should be discussed with the caretakers. Depend-
ing on the severity of the atresia, a surgical repair might 
be effective in terms of hearing outcomes, taking risks and 
complications into consideration. This seems feasible in the 
minority of the atresia cases. Another option is a hearing 
implant, i.e. a bone conduction device (BCD) or middle ear 
implant [7, 8]. To discuss these types of hearing implants 
with the caretakers requires expertise and experience. The 
risks and complications need to be discussed, especially in 
respect of the congenital anomalies. In case of revalidation 
of the hearing by means of a BCD, it is important to mention 
a percutaneous BCD is associated with the best output [9].
Whereas the hearing loss is obvious in patients with con-
genital atresia, hearing loss can also occur in patients with 
an acquired absent auricle and hearing therefore always 
requires attention [4, 10].
Three different approaches can be chosen regarding the 
management of the auricle [11]: (1) accept and wait, where 
the patient chooses to leave the absent auricle untreated after 
being informed at the auricle consultation, (2) an auricular 
prosthesis, the patient chooses to have his auricle recon-
structed using an implant- or adhesive-retained prosthesis, 
(3) a reconstruction of the auricle whereby the auricle is 
reconstructed using autologous rib cartilage or porous 
polyethylene.
An auricular prosthesis is an alternative to the autologous 
and alloplastic reconstruction of the auricle. Advantages 
such as the short procedure, possible under local anaesthesia 
and usability in compromised tissues make this an excellent 
option in patients with medical comorbidities and oncologi-
cal patients [12]. Also, a prosthesis is indicated after failed 
autologous reconstruction and can be indicated primarily in 
microtia, depending on the patient’s preference [13]. Nowa-
days, an auricular prosthesis also has a great aesthetic and 
realistic appearance.
To attach the auricular prosthesis, an adhesive substance 
or osseointegrated implants can be used. An adhesive-
retained prosthesis has a few disadvantages compared to an 
implant-retained prosthesis: it is easily dislocated and has 
a chance of adverse tissue reactions [14]. The use of osse-
ointegrated percutaneous implants has minimized these dis-
advantages, although the implants themselves require daily 
maintenance and skin infections do occur [15]. The concept 
of osseointegration with titanium implants was first imple-
mented in dental medicine in 1965 by Brånemark [16]. In 
1977 osseointegrated implants were introduced for the first 
time outside the oral cavity by Tjellström, i.e. in the tem-
poral bone for application of bone conduction hearing and 
eventually for auricular prostheses in 1983 [17].
The Brånemark implants were used for many years to 
retain auricular prostheses. The titanium implants used for 
bone conduction hearing have evolved enormously since 
their introduction. In 2010, the most recent design percuta-
neous bone implant (the BIA300) was developed for bone 
conduction hearing. This new design with an increased 
bone-to-titanium surface showed advantages compared 
to the previous generation implants in terms of adverse 
skin reactions and implant stability [18, 19]. As a result, 
 Vistafix® implants (VXI implants) were developed to retain 
auricular prostheses based upon the same BIA300 implant. 
These have been used at the Radboudumc to retain auricular 
prostheses since 2011.
A number of studies have been published describing the 
clinical results of these bone-anchored hearing implants 
[18–21]. However, large data regarding the VXI implants 
are lacking. In this study, we will describe our way of work-
ing in a multidisciplinary approach in the use of osseoin-
tegration-retained auricular prostheses using VXI implants 
and share our experience by retrospectively evaluating the 
surgical procedure, clinical outcome and satisfaction of these 
patients.
Materials and methods
Patient characteristics
All patients who received an auricular prosthesis with Coch-
lear Vistafix VXI300 implants (Cochlear Bone Anchored 
Solutions AB, Mölnlycke, Sweden) at our clinic between 
December 2012 and November 2017 were identified. This 
resulted in a cohort of 11 consecutive patients with 12 
auricular prostheses and a total of 31 VXI implants. The 
average age of the patients at implantation is 44 years and 
6 months. The youngest patient was 13 years and 4 months 
old and the oldest patient was 85 years old at implantation. 
The patient characteristics are shown in Table 1. This retro-
spective study received approval from the local institutional 
ethics committee.
Pre‑operative planning
The computed tomography (CT) scan (ossa petrosa) is used 
to determine the optimal location of the implants to retain 
the prosthesis (See Fig. 1). To define this exact location, it is 
important to assess if sufficient temporal bone is present at 
the preferred location of the implant guaranteeing a symmet-
ric position of the prosthesis. When the ideal position of the 
implant is determined by the ENT-surgeon, anaplastologist 
and Radboudumc 3D laboratory, the virtual implant plan-
ning is transferred to a skin template which is manufactured 
using 3D printing (See Fig. 2). All to assure the most accu-
rate placement of the implant during surgery (See Fig. 3). 
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This type of template is used in all patients implanted with 
VXI implants in our tertiary referral center.
Surgical technique
The surgical procedure starts with shaving hair at the sup-
posed position of the implants. The determined position 
of the implants is marked at the temporal bone with meth-
ylene blue using the 3D-printed skin template (Fig. 4). 
Methylene blue is injected with a needle through the holes. 
The patient’s face is completely visible. If necessary, any 
remnants of microtia or previous reconstruction are removed 
in the same session.
After a semilunar incision 10 mm posterior to the antici-
pated locations of the implants down to level of the perios-
teum, the skin and the subcutaneous flap is developed and a 
cruciform incision is made in the periosteal layer. Usually, 
three implants (at least two) are placed to guarantee optimal 
retention of the prosthesis.
A hole of 4 mm depth is drilled (2000 RPM, with per-
manent watercooling), after which a small countersink is 
created and the first phase of the implant is placed (torque: 
Table 1  Patient characteristics
a Previous surgery = history of auricular reconstruction with rib cartilage in different centres
b SCC = Squamous cell carcinoma
Patient Sex Age Etiology Side Radiotherapy Previous 
 surgerya
1 M 54 Microtia AD – Yes
2 M 19 Microtia AS – Yes
3 M 17 Microtia AS – –
4 M 89 SCCb AD Yes –
5 M 18 Microtia AD – –
6 M 71 SCC AS Yes –
7 M 52 Melanoma AD – –
8 M 86 SCC AD Yes –
9 M 61 Trauma AD – –
10 F 18 Microtia ADS – Yes
11 F 29 Microtia AD – Yes
Fig. 1  Pre-operative planning of the implants using a CT-scan
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45 Ncm, in case of a bony bed first a few turns without irri-
gation, the last turns with adequate watercooling). Before 
positioning of the implant, the entity of the bottom (bone 
or dura) is checked by palpation and visual inspection. The 
first implant is placed in a perpendicular direction to the 
bone. In patients ≤ 10 years old or when a problematic skin 
healing is anticipated a two-stage surgery is indicated and 
a cover screw is placed.
In most cases single-stage surgery can be used and 
 Vistafix® abutments (VXA abutments) are placed in the 
same session after all implants have been inserted. No 
magnets or clips were used in the studied patients. All 
patients received a retention bar to connect the implants. 
To ensure parallel positioning of the implants (and abut-
ments), a unigrip screwdriver/implant inserter is used 
to extend the first implant (with the correct perpendicu-
lar position to the bone). The second and, if used, third 
implant are placed in parallel with the first implant and 
not necessarily in perpendicular position with the bone.
Following the trends in bone conduction hearing 
implant surgery, a shift is seen in VXI implant surgery 
from tissue reduction towards tissue preservation the past 
years [22–24]. Nowadays, in most cases the subcutis is 
preserved and skin is closed with resorbable sutures. Only 
in cases of an extensive soft-tissue layer, not enabling the 
use of a 7.5 mm length abutment (maximum available 
length), a tissue reduction is performed. Afterwards the 
skin surrounding the abutment is punched (5 mm biopsy 
punch) and the skin falls closely around the abutment. 
Finally, a healing abutment (6 mm) or healing cap (14 mm) 
and a gauze with antibiotic ointment is given followed by 
a compression bandage.
Fig. 2  Virtual planning of 
implants (left) transferred to a 
skin template (right)
Fig. 3  Surgical template (left) 
and placing over patients face 
pre-operatively (right)
Fig. 4  Marking of the positions of the implant using the template pre-
operatively
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Post‑surgery protocol
All patients had their postoperative visit a week after surgery 
when the head dressings were removed. Healing caps were 
removed and replaced by healing abutments, which stay in 
position until 3–5 weeks after surgery.
Parallel to this follow-up, the patient is seen by the ana-
plastologist 3–5 weeks after implantation, who manufactures 
the auricle. At this visit, the Cochlear impression coping 
squared for VXA abutments are placed on the abutments 
and an impression is made using silicon. Next, the abutment 
replica’s for VXA abutments are placed on the impression 
copings and the impression is poured in plaster to create 
a replica of the situation of the patient’s head around the 
implants.
Using the CT scan made to manufacture the surgical tem-
plate, the contralateral ear is mirrored by the 3D laboratory 
and printed in a plastic material (Oceanz BV, Ede, The Neth-
erlands). A template is made of this plastic ear with silicon, 
which is poured with wax to make a wax ear. In case of a 
bilateral absent auricle, the appearance of the prosthesis is 
determined by the shape of the patient’s face or an impres-
sion of the ear of a relative is used.
Subsequently, this wax ear is fitted to the plaster model 
with the VXA abutment replica. This plaster model with 
abutment replica and the wax ear is sent to Pro Scan (Zon-
hoven, Belgium) to design and mill a titanium suprastruc-
ture, which is placed on the VXA abutment replica. A tem-
plate of the suprastructure is made with silicon, which is 
then used to duplicate the suprastructure with epoxy die 
material and then poured with plaster to create a replica of 
the plaster template with VXA abutment replicas with the 
suprastructure.
The medial aspect of the wax ear is adjusted to fit Fria-
dent Gold Bar Clips (Dentsply, Sevenum, The Netherlands) 
to retain de prosthesis, and the residual space is filled with 
a transparent plastic acryl carrier (Candulor, Rielasingen-
Worblingen, Germany). The wax ear can now be attached to 
the suprastructure or its duplicate. Then, the titanium supras-
tructure is placed on the patient’s abutments and the wax ear 
is adjusted to fit smoothly with the patient’s soft tissue. Also, 
a scan of the patient’s skin is made using a spectrocolorim-
eter to determine the base colour of the prosthesis (e-Skin®; 
Spectromatch, Bath, UK).
The wax ear attached to the plaster model including the 
duplicate suprasturcture is placed in a cuvette and imbedded 
with plaster. This cuvette is heated and washed to remove 
the wax from the cuvette.
The carrier is treated with a platinum primer G611 to 
ensure attachment with the future silicon prosthesis.
Silicon M511 A/B (Technovent, York, UK) is weighed 
and the colors’ ratio, determined with the spectrocolor-
imeter, is added. The ear is further colorized on particular 
locations using Short Veining Fibres P601 and flocking 
(Technovent, York, UK), with the patient present. This 
blend is placed in the plaster template in the cuvette, which 
is thereafter pressurized to lose the redundant silicon and 
air. The silicon is hardened in the oven. After some minor 
last adjustments, the silicon ear is ready to be placed on the 
patient (Fig. 5).
The implants are loaded from 3 to 5 weeks postop-
eratively, comparable with the early loading of the BI300 
implants used for hearing rehabilitation with a bone conduc-
tion device [25]. The prosthesis is susceptible to discolora-
tion by sunlight and therefore needs to be replaced every 1 
or 2 years, depending on the patients’ needs and is taken care 
of within the yearly follow-up with the anaplastologist [11].
Further follow-up visits for the implant and prosthesis are 
scheduled after 3, 6 and 12 months followed by yearly visits 
in a multidisciplinary team. During these visits, implant sta-
bility was assessed manually and the surrounding skin was 
evaluated using the Holgers scale [26].
Outcome measurements
To evaluate the results of the implantation with VXI 
implants, we studied several parameters.
Complications, i.e. implant loss, soft-tissue reactions and 
the necessity of revision surgery were assessed using the 
patients’ medical files. Also, outpatient changes in abutment 
length were assessed. Soft-tissue reactions were assessed 
using the Holgers scale [26]. A Holgers grade equal to two 
or higher is considered clinically relevant and requires medi-
cal treatment. Further characteristics of implantation like 
number of implants, depth, implant length, bottom of the 
drill hole, single or two-stage surgery and whether skin is 
reduced were assessed and are assembled in Table 2.
Fig. 5  Implants (left) and prosthesis (right)
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As subjective outcome, we measured the satisfaction of 
the patient after implantation and loading of the prosthesis 
by means of the Glasgow benefit inventory (GBI) question-
naire [27]. This is an 18-item questionnaire which assesses 
the subjective benefit postoperatively, within four different 
domains: total score, general satisfaction, social benefit and 
physical benefit. Each question is scored using a five-point 
Likert scale ranging from large improvement to large dete-
rioration. Total scores range from − 100 (maximal deteriora-
tion), 0 (no effect) to + 100 (maximal improvement).
Basic statistics were performed using IBM SPSS statis-
tics, version 25.
Results
Implant and surgery characteristics
The implant and surgery characteristics are shown in 
Table 2.
Four patients had a history of previous auricular recon-
struction surgery with autologous rib cartilage in a different 
center, and three patients had received radiotherapy treat-
ment involving implant site. A total of 31 VXI implants were 
implanted in 11 patients, retaining 12 auricular prostheses. 
Depending on the availability of appropriate bone and the 
patients’ anatomy, the majority the prostheses were loaded 
on three (n  = 7; 58%) implants, the others were based upon 
two (n = 5; 42%). All VXI implants had a length of 4 mm, 
except for one. This third implant was mobile during implan-
tation. A second 3 mm implant was placed in a different 
position with presumed sufficient stability. It was decided 
not to load this specific implant with an abutment primarily, 
since the other two could be used. In three implants (10%) 
the bottom of the drillhole was dura and bony in all other 
implants (90%). Both 6 mm and 7.5 mm abutments were 
used on the implants, based on the thickness of the skin/
subcutis. For most of the implants a 7.5 mm abutment was 
placed (n = 18; 58%). A 6 mm abutment was placed on 11 
implants (35%) and on two implants (7%) no abutment was 
placed. The first case was described above (3 mm implant), 
and in the second case it was decided to place a third implant 
fixture as a sleeper to anticipate on possible future implant 
loss as a result of the postoperative radiation therapy.
In the surgical procedures for seven prostheses, the tis-
sue around the implants was preserved (58%), while soft-
tissue reduction was performed around the implants in 
five prostheses (42%). In all cases the VXI implants were 
implanted using single-stage surgery, except for two cases 
(17%). In one case a single-stage surgery was not possible 
due to absence of an instrument to attach the abutment to the 
implant. In the other case a two-stage surgery was chosen 
above a single-stage surgery in consultation with the patient. 
The patient did not want to lose his skin adhesive prosthesis 
during the time the implants could not be loaded.
Post‑surgery outcome
During the follow-up, no implants were lost, no revision 
surgery was required and there was no change in abutment 
length. Minimal follow-up time was 7 months and the 
average follow-up time was 2 years and 7 months. Three 
of the patients who had their auricle amputated due to a 
malignancy had received radiotherapy treatment prior to 
Table 2  Implant and surgery 
characteristics
a Numbers noted when not all bottoms had the same entity
b Inferior implant 3 mm, on which no abutment is placed
c No abutment was placed on anterior implant
Patient No. of 
implants
Length of 
implants (mm)
Bottom (N)a Length of abut-
ments (mm)
Tissue 
reduction
One- or two-
stage surgery
1 2 4 Bone 7.5 Yes 2
2 3 4 Bone 7.5 Yes 1
3 3 4 Dura (1)
Bone (2)
6 Yes 2
4 3 4 Bone 6 Yes 1
5 3 4 Bone 7.5 No 1
6 3 4b Bone 7.5 No 1
7 2 4 Bone 7.5 No 1
8 3 4c Bone 7.5 Yes 1
9 2 4 Bone 7.5 Yes 1
10. AD 2 4 Bone 6 No 1
10. AS 3 4 Dura (1)
Bone (2)
7.5 No 1
11 2 4 Dura (1) Bone (1) 7.5 and 6 No 1
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the implantation of the VXI implants. One of these three 
patients received additional radiotherapy treatment post 
implantation.
The patients visited the outpatient clinic for postop-
erative follow-up 30 times in total where an assessment 
of the implant and soft tissue is done, resulting in 91 
observations in total. Soft-tissue reactions were recorded 
using the Holgers classification. A Holgers grade 0 was 
observed in 70.3% of the visits and a Holgers grade 1 
in 8.8%. A Holgers grade 2 was observed in 16.5% and 
a Holgers grade 3 in 4.4%. No Holgers grade 4 was 
observed.
A Holgers grade 2 soft-tissue reaction or higher is 
noted as an adverse soft-tissue reaction and an indication 
for treatment with at least a locally applied antibiotic and 
corticosteroid ointment. This was observed at least once 
in ten implants (32.2%), during 19 observations (20.9%) 
and in at least three patients (27.2%), two of which had 
undergone tissue reduction, one patient with tissue pres-
ervation during implantation. Within the three patients 
who received pre-amputation radiotherapy, in one patient 
a Holgers grade 2 was observed once.
All skin reactions resolved after topical treatment with 
antibiotic/corticosteroid ointment. In two patients, the 
Holgers score was determined by how the skin around the 
implant was clinically looking while reviewing the files.
In the total follow-up time of 29.6 years, 24 prostheses 
were manufactured. The average lifespan of one prosthe-
sis thus amounts to 1.2 years in the studied patients. The 
post-surgery outcome is shown in Table 3. The distribu-
tion of the maximum Holgers score observed per prosthe-
sis is shown in Table 4.
Subjective outcome measurements
All 11 patients were asked to fill out the GBI, which was 
sent by e-mail or was filled in during follow-up visits. The 
patients filled out the GBI at various follow-up lengths. Ten 
patients responded (response rate 91%). Every patient that 
filled in the questionnaire reported a positive score. The GBI 
displayed a positive change in overall health status with an 
average score of 25.8 (median 30.6; range 8.3–36.1). The 
average scores in the general domain were 38.4 (median 
45.8; range 16.7–55.6), in the social domain 0 and in the 
physical domain − 3.3 (median 0; range − 16.7 to 0).
Discussion
Main findings
In this study, we have evaluated the surgical procedure, clini-
cal outcome and satisfaction of the patient of osseointegra-
tion-retained auricular prostheses using VXI implants. Clini-
cal outcome was assessed by complications and subjective 
outcome was measured using the GBI.
Table 3  Post-surgery outcome Patient Implant loss Max Holgers 
Score
Revision 
surgery
Length of abut-
ment changed
Follow-up length 
(in years)
No. 
prosthe-
ses
1 – 0 – – 5.13 3
2 – 2 – – 4.21 3
3 – 1 – – 4.06 2
4 – 2 – – 3.96 1
5 – 3 – – 3.81 4
6 – 0 – – 2.13 2
7 – 0 – – 1.58 1
8 – 1 – – 1.55 2
9 – 0 – – 0.85 1
10. AD – 0 – – 0.84 2
10. AS – 0 – – 0.84 2
11 – 0 – – 0.59 1
Table 4  Distribution maximum Holgers Score
a Total of 10 unilateral and 1 bilateral prostheses
Maximum Holgers Score Population (n = 12)a
Grade 0 7 (58.3%)
Grade 1 2 (16.7%)
Grade 2 2 (16.7%)
Grade 3 1 (8.3%)
Grade 4 0
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During the follow-up with an average of 2 years and 
7 months no implants were lost, implying an implant sur-
vival rate of 100%. Three patients (ten implants) received 
local treatment because of an adverse soft-tissue reaction 
(Holgers 2 or higher). Two of these patients received treat-
ment once during the follow-up, while the other patient 
received treatment four times. Revision surgery or a replace-
ment of abutments was not needed during the follow-up.
All patients who filled in the questionnaire reported a 
benefit in quality of life after implantation and receiving 
their prosthesis (average score 25.8). It should be noted that 
none of the patients reported no benefit nor disadvantage in 
the social domain (all scores on specific questions were 0) 
and that two patients (18%) reported a disadvantage (− 3.3) 
in the physical domain after implantation (the rest reported 
0 on the specific questions). This suggests that wearing the 
prosthesis has no adverse effects or benefit in the social 
domain of the patients, and there might be a slight physical 
disadvantage wearing the prosthesis.
Comparison with other studies
Clinical outcome
In other studies conducted in patients with implant-retained 
auricular prostheses, an adverse soft-tissue reaction, requir-
ing treatment, was reported in 3.5–10.4% of the observations 
[28–31]. Jacobsson et al. reports adverse tissue reactions in 
9.68% of the observations in a paediatric population [31]. 
Tzortzis et al. reports a higher incidence of adverse soft-tis-
sue reactions in children compared to adults (Holgers grade 
2 or higher, 28 vs. 3% of the patients) [32].
The frequency of an adverse tissue reaction in our studied 
group (27.2% of the patients, 20.9% of the observations) is 
possibly higher due to the proportion of paediatric patients 
(36.3% of the patients in this study). The limited number of 
patients could be another explanation for the differences in 
frequency.
Until recently, all soft-tissue reactions were observed 
using the Holgers scale in our clinic. Since a new scale was 
designed to assess the soft-tissue reaction more objectively, 
the IPS-scale [33], we recommend to use this IPS scale in 
VXI implants as well. This scale comprises of three differ-
ent parts: inflammation, pain, and skin height/ skin numb-
ness. Depending on the different scores, a standardised 
treatment advice is proposed. This results in a complete and 
objective assessment of reporting soft-tissue reactions after 
implantation.
A remarkable outcome is the fact that revision surgery 
was not needed in our patients whereas in the literature, also 
in bone-anchored hearing, the reported necessity for revi-
sion surgery varies considerably, even up to approximately 
one-third of the patients [28, 31, 32, 34]. This might be 
associated with different surgical techniques (tissue preser-
vation vs. tissue reduction [22–24]). The number of patients 
described with both techniques in this study is, however, too 
small to draw firm conclusions.
A tendency is seen towards the favourable outcomes 
after tissue-preservation techniques. The tissue-preservation 
technique used in the majority of the studied patients, may 
lead to less revision surgery, similar to the effects seen in 
temporal bone implants for bone-anchored hearing [22–24]. 
During the implant surgery, the skin is either preserved or 
reduced (6 patients vs. 5 patients, respectively). The sur-
gical technique for osseointegrated bone-anchored hearing 
implants used to consist of one step where subcutaneous 
tissue is removed to the level of the periosteum. Since wider-
diameter implants have higher survival rates enabling higher 
abutment lengths, tendency is to preserve this subcutaneous 
tissue. Studies show a better clinical outcome compared to 
the removal of subcutaneous tissue and is easier and faster 
[22–24, 35].
Future prospective and large-scale studies are needed to 
strengthen and supplement the clinical outcomes in the cur-
rent retrospective evaluation with osseointegrated implants 
used to retain auricular prostheses.
Subjective outcome
The results on the GBI are comparable to other studies which 
used the GBI to assess benefit after prosthesis or alloplastic 
auricular reconstruction [28, 36, 37]. Kievit et al. reported 
an average score of 22.5 in patients with auricular prosthesis 
and an average score of − 1.7 in the physical domain [28]. 
Braun et al. reported an average score of 21.2 in patients 
with auricular reconstruction using a porous polyethylene 
implant [37]. However, a higher score is reported in autol-
ogous auricular reconstruction. Soukup et al. reported an 
average score of 48.1 in patients with auricular reconstruc-
tion using costal cartilage [36]. We do not have an explana-
tion for this remarkable difference. Our hypothesis was that 
the average scores would be similar between the different 
techniques. The score reported by Soukup et al. is similar 
to the score reported score after rhinoplasty in adolescents, 
where the average score was 53.8 [38].
Limitations
This study has a few limitations, which are important to 
address. First, retrospective studies are known to be prone 
to missing information while reviewing patient’s files. In 
this studied group, the Holgers score was not noted in two 
cases in which the maximum Holgers score was determined 
by how the skin around the implant was clinically looking. 
Second, due to the low incidence of an absent auricle among 
Dutch patients and the introduction of VXI implants after 
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2010, the sample size of this studied group is small in an 
absolute manner. Relatively, however, most patients in need 
of a prosthesis are treated in our center. To assess clinical 
and subjective outcome more accurately and to be able to 
draw firm conclusions, bigger sample sizes are preferable.
Pre‑operative 3D planning
In all patients, the placement of the implant was preceded by 
a CT scan to determine the optimal location of the implants 
and a template was manufactured to assure the most accurate 
placement. With the use of this pre-operative planning and 
surgical template a higher accuracy and precision can be 
achieved in positioning of the implants [39]. This facilitates 
the anaplastologist to design the auricle prosthesis in an opti-
mal way, without having to compromise on the position of 
the fixation clips at the medial aspect of the prosthesis. Thus, 
the auricle will have an appealing shape and facial position, 
with optimal protrusion and ventilation.
Implant loading
After the implantation of the studied VXI implants, the 
implants were loaded after 3–5 weeks. Originally, the time 
between implantation and implant loading was about 3–6 
months to ensure completion of the osseointegration pro-
gress and implant stability. Recently, studies have been pub-
lished about early implant loading in BIA300 implants for 
hearing revalidation. These studies show that loading the 
implant after 3–4 weeks postoperatively is safe and does 
not result in more implant loss or osseointegration failure 
[25, 40, 41]. These data in patients with implants retaining 
bone conduction devices resulted in the tendency to shift to 
early loading of the implants for retaining prosthesis. The 
fact no implants were lost in the patients in this study is 
encouraging, however, further clinical studies are needed to 
demonstrate if the results are consistent in osseointegrated 
implants used to retain auricular prostheses.
Auricular prostheses in cancer patients
An auricular prosthesis can also be a part of the treat-
ment in patients with ablative surgery as a result of any 
form of cancer or trauma. However, where some patients 
are happy the cancer is treated and accept the absence of 
the auricle, other patients would like to have their auricle 
reconstructed. Reconstruction with an auricular prosthesis 
is recommended in these patients [12]. The treatment of 
patients with a carcinoma of the auricle or external audi-
tory meatus usually consists of accessory radiotherapy 
in the destined region of implantation. Is has previously 
been described that radiotherapy implies higher risks of 
complications and implant loss when implantation follows 
radiotherapy in the craniofacial area [42]. Therefore, some 
clinicians advise to place implants (without abutment) 
at the same time as ablative surgery, to obtain sufficient 
osseointegration [43]. We advocate a patient-orientated 
perspective, where our first goal is to create a safe situa-
tion without carcinoma in the temporal bone. The possi-
bility of ear reconstruction with an auricular prosthesis is 
discussed after the patient is recovered, both psychologi-
cally as physically. This approach improves quality of care 
advocating shared decision-making and optimal implant 
positioning can be guaranteed. Our experience with the 
currently used wider-diameter implants, mainly used in 
bone-anchored hearing implants, as well as the encourag-
ing results of 3 out of 11 patients in this population, is 
that they are safe to use after radiotherapy, which is also 
suggested in the literature [44].
Conclusion
This study describes the work-up of patients with a miss-
ing auricle opting for implant-retained prostheses. No 
implants were lost in our total cohort of patients with an 
absent auricle due to microtia, trauma or cancer of the 
auricle and/or external auditory meatus. No revision sur-
gery was needed in an average follow-up period of more 
than 2.5 years. The VXI implants used are a safe and reli-
able treatment option for retaining auricular prostheses 
in patients with an absent auricle. Adverse skin reactions 
appeared in 32.2% of the implants and in 27.2% of the 
patients, resolving after treatment with an antibiotic oint-
ment. In general, patients were satisfied with their auricu-
lar prosthesis and showed benefit in quality of life. Further 
studies with larger numbers and preferably a prospec-
tive character is needed to draw statistically significant 
conclusions.
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